NCT00649597View on ClinicalTrials.gov

Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy
Interventions
DRUG

Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg

20/25mg, single dose fasting

DRUG

Lotensin HCT® Tablets 20 mg/25 mg

20/25mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY